uk-dgm MCQ (SBA): SGLT2 Inhibitor as Second-Line in Type 2 Diabetes

Instant feedback + full explanation. One question, done properly.

ModeratePolypharmacy & PrescribingSGLT2 Inhibitor as Second-Line in Type 2 Diabetesuk-dgm

A 74-year-old woman with type 2 diabetes, CKD stage 3a (eGFR 54), and hypertension is seen in the diabetes clinic. Her HbA1c is 66 mmol/mol on Metformin 1 g BD alone. According to NICE NG28, what is the MOST appropriate second-line agent to add?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dgm MCQ: SGLT2 Inhibitor as Second-Line in Type 2 Diabetes — Answer